Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Accumulated Expenses (2021 - 2024)

Lucid Diagnostics (LUCD) has disclosed Accumulated Expenses for 4 consecutive years, with $64000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Accumulated Expenses fell 33.33% year-over-year to $64000.0, compared with a TTM value of $64000.0 through Dec 2024, down 33.33%, and an annual FY2024 reading of $64000.0, down 33.33% over the prior year.
  • Accumulated Expenses was $64000.0 for Q4 2024 at Lucid Diagnostics, down from $96000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $2.2 million in Q1 2022 and bottomed at $64000.0 in Q4 2024.
  • Average Accumulated Expenses over 4 years is $767790.4, with a median of $557000.0 recorded in 2021.
  • The sharpest move saw Accumulated Expenses surged 57.81% in 2022, then plummeted 89.08% in 2023.
  • Year by year, Accumulated Expenses stood at $557000.0 in 2021, then surged by 57.81% to $879000.0 in 2022, then tumbled by 89.08% to $96000.0 in 2023, then tumbled by 33.33% to $64000.0 in 2024.
  • Business Quant data shows Accumulated Expenses for LUCD at $64000.0 in Q4 2024, $96000.0 in Q4 2023, and $879000.0 in Q4 2022.